Biomedicines Webinar | Alzheimer’s Disease: The History of Forgetting
the chair
3rd Biomedicines Webinar
Alzheimer’s Disease: The History of Forgetting
We are presently celebrating the 115th anniversary of Alzheimer´s disease discovery. As a recognition of this milestone, we have gathered worldwide contributions in a very relevant special issue entitled “Alzheimer's Disease—115 Years after Its Discovery”. To celebrate the success of our special issue, it is our great pleasure to welcome you to the Biomedicines webinar “Alzheimer´s disease: the history of forgetting”. This online conference will be an opportunity to have an overview of the state-of-the-art of this interesting story including the important recent advances and the latest research and milestones in AD research. This will be an excellent opportunity to interact virtually with world experts in the AD field.
Date: 15 December 2022
Time: 10:00 am CET | 4:00 am EST | 5:00 pm CST Asia
Webinar ID: 853 0652 3668
Webinar Secretariat: biomedicines.webinar@mdpi.com
Meet Our Speakers
Dr. Cristina Carvalho
Center for Neuroscience and Cell Biology, University of Coimbra, Portugal; Center for Innovation in Biomedicine and Biotechnology (CIBB); Institute for Interdisciplinary Research, University of Coimbra, Portugal;
Cristina Carvalho graduated in Biology from the University of Coimbra (UC) in 2007 and in the same year she was qualified to attend the specialized master program in Cellular and Molecular Biology at the Faculty for Science and Technology of UC (FCTUC), program that she finished in 2008 with a score of 18 in 20 values. After, she started her PhD in the same University in the beginning of 2009 and obtained her Ph.D. degree in Cellular Biology from the University of Coimbra in 2013. Presently, she is committed to deeply explore the mechanisms underlying type 2 diabetes-associated neurodegeneration in order to achieve knowledge of possible therapeutic targets that could be used as preventive strategies. She is involved in several projects and is responsible for several laboratory tutoring of master students (lab rotations and development of MSc work plans). Besides her individual research project, she participates in different projects. Cristina has a remarkable CV comprising 10 book chapters and over 50 papers in international peer-reviewed journals, including a publication in Diabetes journal with an IF=8.3 and, more recently (2022), a paper in Cellular and Molecular life Science with an IF=9.2. In total she has over 4000 citations and a h-index of 32 (according with google scholar). More, her international scientific recognition is reflect by some awards/distinctions/honors including a recent recognition as an Expertscape Expert in Alzheimer Disease by the Expertscape Recognition Program (2021). Currently she is ad-hoc reviewer in several international peer-reviewed journals and she is also guest editor in 4 different special issues in BBA, Antioxidants and Biomedicines journals. In 2021, she won an ESCI EXPLORATORY RESEARCH GRANT to perform a pilot study in animal models of T2D, and a FCT Exploratory research project (start date: 01/01/2022) allowing her to go a step further in the development of her hypothesis.
Dr. Susana Cardoso
Center for Neuroscience and Cell Biology, University of Coimbra; Center for Innovation in Biomedicine and Biotechnology (CIBB); Institute for Interdisciplinary Research, University of Coimbra, Portugal;
Susana Cardoso graduated in Biology in 2008 from the Faculty of Sciences and Technology of University of Coimbra, Portugal, where she also received her PhD degree in Cellular Biology in 2013 after a scientific internship at the Yale University School of Medicine, USA. She conducted her postdoctoral research at the Center for Neuroscience and Cell Biology, University of Coimbra, where presently she is a doctorate researcher. Her research interests have been focused in exploring the field of metabolic disorders like diabetes and its interplay with neurodegenerative diseases, particularly Alzheimer's disease, giving an emphasis on mitochondria (energy, homeostasis and signals) role in this link. During her research path, she has been actively enrolled in the supervision and tutoring of several students (lab rotations and investigation chairs, master students); is an ad-hoc reviewer of manuscripts for several renowned international Journals; has been the Guest-Editor of several Special Issues and has participated in different society education activities. She has also received some awards/distinctions/honors including a recent recognition as an Expertscape Expert in Alzheimer Disease by the Expertscape Recognition Program (2021). In her curriculum it can be found >45 scientific peer-reviewed papers with over 3439 citations and an h-index of 30, according to Google Scholar. She has integrated the research team of some previously funded research projects as collaborator and as Co-PI.
Dr. Sónia Correia
Center for Neuroscience and Cell Biology, University of Coimbra; Center for Innovation in Biomedicine and Biotechnology (CIBB); Institute for Interdisciplinary Research, University of Coimbra, Portugal;
Sónia C. Correia is presently a doctorate researcher at the MitoBD - Mitochondria in Brain Disorders research group from the Center for Neuroscience and Cell Biology (CNC) and her academic background includes: BSc in Biology (2007) and PhD in Cell Biology (2012) from the University of Coimbra. During her postdoctoral training, Sónia acquired international experience in Case Western Reserve University (Cleveland, Ohio - USA). The scientific career of Sónia has been devoted to demystify the pathological basis of Alzheimer’s disease (AD) in order to identify new and feasible peripheral biomarkers for the early diagnosis of the disease and promising therapeutic targets able to counteract the AD symptomatology and neuropathology in a timely manner. Particularly, Sónia is interested in unveiling the contribution of abnormal mitochondrial dynamics and hampered adaptative response to hypoxia triggered by the family of transcription factors HIFs to the onset and progression of this devastating neurodegenerative disease. Despite the interruptions in her scientific career due to maternity leaves (2016/2018), Sónia published >50 papers in international peer-review journals, including a publication in Antioxidants & Redox Signaling IF=8,401 in 2022, with an overall h-index=37 or 32 and >4700 or 3300 citations, according to Google Scholar or Scopus respectively. In parallel, she also integrates the editorial board of Biomedicines and Frontiers in Cellular Neuroscience – Cellular Neuropathology, is an active reviewer in the Alzheimer's Association Research Fellowship Program, and Guest-Editor of special issues for Biomedicines and International Journal of Molecular Sciences. In 2010, Sónia won the ASN Neuro Poster Prize sponsored by the American Society of Neurochemistry. More recently, Sónia was recognized as an Expert in Alzheimer’s Disease by the Expertscape, an online base of biomedical expertise.
Sponsors and Partners
Organizer
Boosted by the success of the Special Issue “Alzheimer's Disease -115 Years after Its Discovery”, the 3rd Biomedicines webinar was held on 15 December 2022. With the theme “Alzheimer’s Disease: The History of Forgetting”, this online event was graced with the participation of two renowned researchers in the field of Alzheimer's disease. In the first presentation, Dr. Isabel Cardoso discussed her work on “The Importance of TTR in Alzheimer´s Disease”. Thereafter, an amazing talk on “APOE Genotype Specific Differences in HDL in Alzheimer’s Patients” was given by Dr. Angela Zivkovic. The presentations were followed by a Q&A session moderated by the Chairs. The webinar was offered via Zoom and required registration to attend. If you missed this webinar, the full recording can be found here on Sciforum website. To stay updated on the next webinars on Biomedicines, be sure to sign up for our newsletter by clicking on "Subscribe" at the top of the page.
Guest Editors: Dr. Susana Cardoso, Dr. Cristina Carvalho & Dr. Sónia Catarina Correia
Deadline for manuscript submissions: 31 December 2022